It has potential:
Only 10% of patients with frostbitten fingers or toes who received tissue plasminogen activator (tPA) required amputation of necrotic digits, compared with 41% of patients who didn’t get thrombolytic therapy.
It has potential:
Only 10% of patients with frostbitten fingers or toes who received tissue plasminogen activator (tPA) required amputation of necrotic digits, compared with 41% of patients who didn’t get thrombolytic therapy.
Get free updates delivered free to your inbox.
Comments are moderated before they are published. Please read the comment policy.